This cohort study assessed the accuracy of the CHA2DS2-VASc score for predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation.
This randomized clinical trial reports that mechanical left atrial appendage closure was noninferior to warfarin for preventing stroke, systemic embolism, and cardiovascular death.
This commentary discusses a cohort study published in JAMA Surgery that investigated the association between inpatient surveillance for venous thromboembolism and risk of postdischarge venous thromboembolism.
This Viewpoint discusses low public awareness about risk factors for and symptoms of venous thromboembolism and proposes quality initiatives that might improve recognition of venous thromboembolism and outcomes for patients.
This randomized trial compares the efficacy and safety of tinzaparin vs warfarin for treatment of acute, symptomatic venous thromboembolism in patients with active cancer.
This JAMA Clinical Evidence Synopsis describes the association of long-term duration vs short-term duration of vitamin K antagonist therapy among patients with venous thromboembolism.